PharmaEssentia Corporation (LUX:261280523)
16.10
-0.10 (-0.62%)
At close: Nov 10, 2025
PharmaEssentia Revenue
PharmaEssentia had revenue of 3.89B TWD in the quarter ending September 30, 2025, with 43.50% growth. This brings the company's revenue in the last twelve months to 13.82B, up 66.04% year-over-year. In the year 2024, PharmaEssentia had annual revenue of 9.73B with 90.67% growth.
Revenue (ttm)
13.82B TWD
Revenue Growth
+66.04%
P/S Ratio
11.96
Revenue / Employee
105.46M TWD
Employees
131
Market Cap
4.62B EUR
Revenue Chart
* This company reports financials in TWD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.73B | 4.63B | 90.67% |
| Dec 31, 2023 | 5.11B | 2.22B | 77.15% |
| Dec 31, 2022 | 2.88B | 2.23B | 339.00% |
| Dec 31, 2021 | 656.51M | 99.25M | 17.81% |
| Dec 31, 2020 | 557.26M | 251.57M | 82.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reinet Investments S.C.A. | 798.00M |
| Socfinaf | 663.01M |
| Socfinasia | 199.82M |
| CPI FIM | 182.41M |
| Luxempart | 97.19M |
| Fotex Holding S.E. | 42.87M |
| Velcan Holdings | 2.99M |